TICKER CODE : CFMS Company Name: CONFORMIS INC Industry : Health Technology . Medical Specialties Position Proposed: BUY Entry : NOW READY (0.8836-1.2428) 1st Partial Take Profit: 1.5501 (AUG 2021-OCT 2021) 2nd Partial Take Profit: 2.0080 (Early Jan 2022-March 2022) Expected Take Profit: 3.9000 (July 2022- OCT 2022) STOP LOSS: 0.4617 Technical Analysis: 1....
First of all, I thanks all those who supported me in last week,specially Muhannadmawed, gv1990, TradingView,and John71505. 1-ADTX @ 3.60 2-AKRO @ 31.06 3-AMC @ 3.51 4-AMD @ 92.79 5-BYND @ 140.70 6-CFMS @ 1.40 7- CRM @ 225.77 8-EYES @ 1.94 9- FUBO @ 37.72 10- GNUS @ 1.57 11- JE @ 6.85 12- KIRK @ 28.07 13- KODK @ 9.46 14- LYL @ 2.71 15- MTC @ 2.44 16- NIO @...
Have you ever heard of Nicholas Darvas??? Nicolas Darvas was a dancer, self-taught investor and author. He is best known for his book, "How I Made $2,000,000 in the Stock Market." He wrote his book 60 years ago and his methodology still works! Conformis is a crystal clear example, by looking at the previous time that 20 SMA crossed up 50 SMA you will find out that...
CFMS still within its "gap zone" from when it gapped down previously . However, the price continued higher today. But volume is a bit slower on Wednesday. Can this technically continue higher if volume continues to be this low compared to Tuesday? "It emerged that the company entered into a lucrative agreement with Stryker Corporation. Stryker is one of the...
Conformis Inc. (Nasdaq: CFMS) is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture & sell patient specific joint replacement implants. The implants are designed to fit each patient's unique anatomy. CFMS stated in their previous ER (July 31, 2019), the company was updating their 2019 outlook...
ConforMIS, Inc. operates as a holding company, which engages in the development, manufacture and sale of joint replacement implants. Its products include iTotal, iUni and iDuo and iJig Instrumentation. The company was founded by Philipp Lang in 2004 and is headquartered in Billerica, MA. SHORT INTEREST 4.8M 08/15/19 P/E Current -2.87 P/E Ratio (with...
ConforMIS (CFMS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock...